← til store investorer
Thurn (Michael Ph.D.) (Chief Executive Officer)
insider
I virksomheder i vores database 1
| Selskab | Andel | Aktier | Rapportdato |
|---|---|---|---|
| Neurizon Therapeutics Ltd | — | 3 487 720 | 2026-03-19 |
annonce
